MDT

101.04

-0.62%↓

A

134.24

-1.9%↓

VEEV

217.58

+0.38%↑

HQY

82.79

-0.1%↓

NEOG

10.23

+1.49%↑

MDT

101.04

-0.62%↓

A

134.24

-1.9%↓

VEEV

217.58

+0.38%↑

HQY

82.79

-0.1%↓

NEOG

10.23

+1.49%↑

MDT

101.04

-0.62%↓

A

134.24

-1.9%↓

VEEV

217.58

+0.38%↑

HQY

82.79

-0.1%↓

NEOG

10.23

+1.49%↑

MDT

101.04

-0.62%↓

A

134.24

-1.9%↓

VEEV

217.58

+0.38%↑

HQY

82.79

-0.1%↓

NEOG

10.23

+1.49%↑

MDT

101.04

-0.62%↓

A

134.24

-1.9%↓

VEEV

217.58

+0.38%↑

HQY

82.79

-0.1%↓

NEOG

10.23

+1.49%↑

Search

Smith & Nephew PLC ADR

Открыт

33.85 -0.73

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

33.8

Макс.

34.26

Ключевые показатели

By Trading Economics

Доход

296M

Продажи

3B

P/E

Средняя по отрасли

30.423

89.037

Дивидендная доходность

2.26

Рентабельность продаж

9.895

Сотрудники

17,000

EBITDA

723M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+3.45% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

2.26%

2.18%

Рыночная статистика

By TradingEconomics

Рыночная капитализация

15B

Предыдущая цена открытия

34.58

Предыдущая цена закрытия

33.85

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

Smith & Nephew PLC ADR График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

27 янв. 2026 г., 23:07 UTC

Отчет

Texas Instruments Says Data Centers, Industrial Recovery Driving Growth into 1Q -- Update

27 янв. 2026 г., 21:27 UTC

Отчет

Texas Instruments 4Q Sales Rise, Profit Falls

27 янв. 2026 г., 23:55 UTC

Обсуждения рынка

Yen Weakens Slightly on Possible Technical Correction -- Market Talk

27 янв. 2026 г., 23:47 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

27 янв. 2026 г., 23:47 UTC

Обсуждения рынка

Nikkei May Decline Amid Caution Over Earnings -- Market Talk

27 янв. 2026 г., 23:39 UTC

Обсуждения рынка

Gold Falls on Likely Technical Correction, Possible Profit-Taking -- Market Talk

27 янв. 2026 г., 23:20 UTC

Отчет

SK Innovation: Asset-Impairment Losses Weighed on Earnings

27 янв. 2026 г., 23:20 UTC

Отчет

SK Innovation: Industry Downturn, Narrower Profit Margins Weighed on Earnings

27 янв. 2026 г., 23:19 UTC

Отчет

SK Innovation Posts Net Loss for Second Consecutive Year

27 янв. 2026 г., 23:19 UTC

Отчет

SK Innovation 2025 Loss KRW5.406T Vs. Loss KRW2.372T >096770.SE

27 янв. 2026 г., 23:18 UTC

Отчет

SK Innovation 2025 Oper Pft KRW448.07B Vs. Pft KRW356.07B >096770.SE

27 янв. 2026 г., 23:18 UTC

Отчет

SK Innovation 2025 Rev KRW80.296T Vs. KRW74.243T >096770.SE

27 янв. 2026 г., 23:11 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

27 янв. 2026 г., 23:11 UTC

Обсуждения рынка

Alkane Resources Bull Positive on Outlook in Red-Hot Gold Market -- Market Talk

27 янв. 2026 г., 23:07 UTC

Обсуждения рынка
Приобретения, слияния, поглощения

Freightways's Australian M&A Adds Ballast to Bull's View -- Market Talk

27 янв. 2026 г., 22:17 UTC

Обсуждения рынка

U.S. Dollar Slips Following Trump Comments -- Market Talk

27 янв. 2026 г., 22:06 UTC

Отчет

Boeing's Stepped-Up Plane Deliveries Lift Sales -- Update

27 янв. 2026 г., 21:51 UTC

Отчет

Texas Instruments Stock Jumps on Strong Outlook -- Barrons.com

27 янв. 2026 г., 21:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

27 янв. 2026 г., 21:43 UTC

Отчет

RTX Stock Jumps After Earnings. It Has 'Great Momentum,' Says CEO. -- Barrons.com

27 янв. 2026 г., 21:41 UTC

Отчет

GM Lost Billions on EVs, Still Beat Wall Street's Expectations -- 5th Update

27 янв. 2026 г., 21:38 UTC

Отчет

These Stocks Are Today's Movers: UnitedHealth, Humana, Micron, Corning, CoreWeave, UPS, GM, and More -- Barrons.com

27 янв. 2026 г., 21:32 UTC

Отчет

Ampol: Modest Profit From F&I International in 2025

27 янв. 2026 г., 21:32 UTC

Отчет

Ampol: F&I Australia Ebit Up by High Single Digit Percent in 2025

27 янв. 2026 г., 21:31 UTC

Отчет

Ampol: New Zealand Ebit in 2025 In Line With Prior Year

27 янв. 2026 г., 21:31 UTC

Отчет

Ampol: Australia Convenience Retail Ebit Up Mid-Single Digit Percent in 2025

27 янв. 2026 г., 21:30 UTC

Отчет

Ampol 4Q Lytton Refinery Production 1.56 Billion Liters

27 янв. 2026 г., 21:29 UTC

Отчет

Ampol FY Unaudited Replacement-Cost Ebitda A$1.44 Billion

27 янв. 2026 г., 21:29 UTC

Отчет

Ampol FY Unaudited Replacement-Cost Operating Profit A$945 Million

27 янв. 2026 г., 21:28 UTC

Отчет

Ampol 4Q Lytton Refiner Margin US$15.14/Bbl

Сравнение c конкурентами

Изменение цены

Smith & Nephew PLC ADR Прогноз

Целевая цена

By TipRanks

3.45% рост

Прогноз на 12 месяцев

Средняя 34.46 USD  3.45%

Максимум 34.91 USD

Минимум 34 USD

Основано на мнении 2 аналитиков Wall Street, спрогнозировавших целевые цены для Smith & Nephew PLC ADR на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

2 ratings

0

Покупка

2

Удержание

0

Продажа

Техническая оценка

By Trading Central

26.64 / 28.37Поддержка и Сопротивление

Краткосрочная

Bullish Evidence

Среднесрочная

Bullish Evidence

Долгосрочная

Bullish Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat